New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Medical students study tampons as possible screening test for cancer

Medical students study tampons as possible screening test for cancer

by Ileana Varela,Florida International UniversityMedical students Jessica Seigel, Leah Cohen and Lauren Dittman are hoping their study leads to a screening test for ovarian cancer. Credit: Flori
Oncology May 13,2024
Medical students study tampons as possible screening test for cancer

Medical students study tampons as possible screening test for cancer

by Ileana Varela,Florida International UniversityMedical students Jessica Seigel, Leah Cohen and Lauren Dittman are hoping their study leads to a screening test for ovarian cancer. Credit: Flori
Oncology May 13,2024
Here's what you can eat and avoid to reduce your risk of bowel cancer

Here's what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady,The ConversationCredit: ready made from PexelsAustralia has one of thehighest rates of bowel cancer in the world. In 2017, bowel cancer was thesecond most common ca
Oncology May 13,2024
Here's what you can eat and avoid to reduce your risk of bowel cancer

Here's what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady,The ConversationCredit: ready made from PexelsAustralia has one of thehighest rates of bowel cancer in the world. In 2017, bowel cancer was thesecond most common ca
Oncology May 13,2024
Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

by St. Jude Children's Research HospitalInvestigators at St. Jude Children's Research Hospital have linked inherited BRCA2 gene mutations with an increased risk of non-Hodgkin lymphoma in
Oncology May 13,2024
Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

Inherited BRCA2 mutations linked to increased risk of childhood lymphoma

by St. Jude Children's Research HospitalInvestigators at St. Jude Children's Research Hospital have linked inherited BRCA2 gene mutations with an increased risk of non-Hodgkin lymphoma in
Oncology May 13,2024
Pancreatic cancer: Less toxic, more enduring drug may improve therapy

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

by Columbia University Irving Medical CenterIn preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are
Oncology May 13,2024
Pancreatic cancer: Less toxic, more enduring drug may improve therapy

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

by Columbia University Irving Medical CenterIn preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are
Oncology May 13,2024
Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

by American Society for Radiation OncologyAdjuvant Radiation Therapy Treatment Options for Early-Stage Invasive Breast Cancer or DCISAbbreviations: DCIS = ductal carcinoma in situ; ER = estrogen
Oncology May 13,2024
Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

Patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS

by American Society for Radiation OncologyAdjuvant Radiation Therapy Treatment Options for Early-Stage Invasive Breast Cancer or DCISAbbreviations: DCIS = ductal carcinoma in situ; ER = estrogen
Oncology May 13,2024
Medical scientists describe optimal immune therapeutic strategies for liver cancer

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion
Oncology May 13,2024
Medical scientists describe optimal immune therapeutic strategies for liver cancer

Medical scientists describe optimal immune therapeutic strategies for liver cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Schematic image of study. Credit: KAISTKAIST medical scientists have presented a novel pathways involving T immune cell exhaustion
Oncology May 13,2024
Progress slow against pancreatic cancer

Progress slow against pancreatic cancer

by Scott Gilbert,Pennsylvania State UniversityAcute exudative pancreatitis on CT scan. Credit: Hellerhoff/WikipediaPancreatic cancer is the third deadliest form of the disease after lung cancer
Oncology May 13,2024
Progress slow against pancreatic cancer

Progress slow against pancreatic cancer

by Scott Gilbert,Pennsylvania State UniversityAcute exudative pancreatitis on CT scan. Credit: Hellerhoff/WikipediaPancreatic cancer is the third deadliest form of the disease after lung cancer
Oncology May 13,2024
Interaction with stromal cells influences tumor growth, metastasis in pancreatic cancer

Interaction with stromal cells influences tumor growth, metastasis in pancreatic cancer

by Massachusetts General HospitalElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteA study from researchers at the Massachusetts General Hospita
Oncology May 13,2024
Interaction with stromal cells influences tumor growth, metastasis in pancreatic cancer

Interaction with stromal cells influences tumor growth, metastasis in pancreatic cancer

by Massachusetts General HospitalElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteA study from researchers at the Massachusetts General Hospita
Oncology May 13,2024
Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks
Oncology May 13,2024
Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks
Oncology May 13,2024
New combination blood test for pancreatic cancer may catch disease earlier

New combination blood test for pancreatic cancer may catch disease earlier

by Van Andel Research InstituteDr. Brian Haab. Credit: Van Andel Research InstituteA new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before
Oncology May 13,2024
New combination blood test for pancreatic cancer may catch disease earlier

New combination blood test for pancreatic cancer may catch disease earlier

by Van Andel Research InstituteDr. Brian Haab. Credit: Van Andel Research InstituteA new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before
Oncology May 13,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com